Ongoing monitoring and adjustments Follow-up visits help us review how youre feeling, answer questions, and decide whether your plan should stay the same or be adjusted
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased in 2.5 mg increments to a target dose of 5-15 mg based on glycemic control and tolerability
Almost every patient who arrives at AgeRejuvenation with chronic fatigue, brain fog, joint pain, autoimmune symptoms, mood disturbances, or skin issues shares one underlying pattern, and most of them have never been told about it
Preclinical studies show promise for GLP1-based therapies in slowing cognitive decline and enhancing brain health, though more research is needed before clinical use in neurodegenerative diseases
Derricks current work centers on the analytical characterization and quantitation of host cell proteins by LC-MS/MS and on building the reference standards and best practices that support process-related impurity analysis across the industry
